Journal: European journal of medicinal chemistry
Article Title: Preparation of novel ring-A fused azole derivatives of betulin and evaluation of their cytotoxicity.
PMID/MRN: 27721148
Publication Date: 2017-Jan-05
Abstract:
An efficient scheme to synthesize novel ring-A fused heterocyclic derivatives of betulin was developed. The starting reaction of this synthesis was one-pot selective bacterial oxidation of betulin to betulone used as the key compound to synthesize the substituted azoles such as C(2)-C(3)-fused 1,2,3-triazoles, oxazoles and 1,2,4-triazine, as well as C(1)-C(2)-fused isoxazoles. The semi-synthetic compounds were screened for their cytotoxic activity against human cancer cell lines A549, HCT 116, HEp-2, MS and RD TE32 with use of the photometric MTT assays. Among the tested compounds, N-acetyltriazole of betulin (10) displayed impressive cytotoxic activity with IC 50 2.3-7.5Ê?M against HCT 116, HEp-2, MS and RD TE32Êcell lines as well as 3-methyl-4-oxido-1,2,4-triazine-derivative of betulonic acid (12) that was active against HCT 116 and HEp-2Êcell lines with IC 50 1.4 and 1.5Ê?M, respectively. Comparative experiments showed triazole (10) to have a lower cytotoxicity to normal epithelial cells, in comparison with compound (12). In accord with the inÊvivo acute toxicity test, the LD 50 of triazole (10) exceeded 600Êmg/kg. The ability of the most potent active triazole (10) to trigger apoptotic cell death was explored in the Annexin V-FITC test and by analyzing of caspase activity and morphological alterations in mitochondria and nuclei of HCT 116Êcells.
Copyright å© 2016 Elsevier Masson SAS. All rights reserved.